Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Gout in males: a possible role for COMT hypomethylation.

Ying X, Chen Y, Zheng Z, Duan S.

Clin Rheumatol. 2019 Jun 4. doi: 10.1007/s10067-019-04607-0. [Epub ahead of print]

PMID:
31165340
2.

CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population.

Li B, Chen X, Jiang Y, Yang Y, Zhong J, Zhou C, Hu H, Duan S.

Immunol Lett. 2017 Oct;190:15-19. doi: 10.1016/j.imlet.2017.06.011. Epub 2017 Jul 6.

PMID:
28690186
3.

Catechol-O-methyltransferase gene promoter methylation as a peripheral biomarker in male schizophrenia.

Gao S, Cheng J, Li G, Sun T, Xu Y, Wang Y, Du X, Xu G, Duan S.

Eur Psychiatry. 2017 Jul;44:39-46. doi: 10.1016/j.eurpsy.2017.03.002. Epub 2017 Mar 30.

PMID:
28545007
4.

Elevated UMOD methylation level in peripheral blood is associated with gout risk.

Yang Y, Chen X, Hu H, Jiang Y, Yu H, Dai J, Mao Y, Duan S.

Sci Rep. 2017 Sep 11;7(1):11196. doi: 10.1038/s41598-017-11627-w.

5.

Catechol-O-methyltransferase promoter hypomethylation is associated with the risk of coronary heart disease.

Zhong J, Chen X, Wu N, Shen C, Cui H, Du W, Zhang Z, Feng M, Liu J, Lin S, Zhang L, Wang J, Chen X, Duan S.

Exp Ther Med. 2016 Nov;12(5):3445-3449. Epub 2016 Sep 28.

6.

Significant association of PRMT6 hypomethylation with colorectal cancer.

Pan R, Yu H, Dai J, Zhou C, Ying X, Zhong J, Zhao J, Zhang Y, Wu B, Mao Y, Wu D, Ying J, Duan S.

J Clin Lab Anal. 2018 Nov;32(9):e22590. doi: 10.1002/jcla.22590. Epub 2018 Jun 21.

PMID:
29927001
7.
8.

Catechol-O-methyltransferase gene methylation and substance use in adolescents: the TRAILS study.

van der Knaap LJ, Schaefer JM, Franken IH, Verhulst FC, van Oort FV, Riese H.

Genes Brain Behav. 2014 Sep;13(7):618-25. doi: 10.1111/gbb.12147. Epub 2014 Jun 24.

9.

DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients.

Nour El Huda AR, Norsidah KZ, Nabil Fikri MR, Hanisah MN, Kartini A, Norlelawati AT.

Psychiatry Clin Neurosci. 2018 Apr;72(4):266-279. doi: 10.1111/pcn.12622. Epub 2017 Dec 27.

10.

Common Variants in LRP2 and COMT Genes Affect the Susceptibility of Gout in a Chinese Population.

Dong Z, Zhao D, Yang C, Zhou J, Qian Q, Ma Y, He H, Ji H, Yang Y, Wang X, Xu X, Pang Y, Zou H, Jin L, Wang J.

PLoS One. 2015 Jul 6;10(7):e0131302. doi: 10.1371/journal.pone.0131302. eCollection 2015.

11.

Promoter hypomethylation of COMT in human placenta is not associated with the development of pre-eclampsia.

Zhao A, Cheng Y, Li X, Li Q, Wang L, Xu J, Xiang Y, Xing Q, He L, Zhao X.

Mol Hum Reprod. 2011 Mar;17(3):199-206. doi: 10.1093/molehr/gaq092. Epub 2010 Nov 3.

PMID:
21047975
12.

The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia.

Lott SA, Burghardt PR, Burghardt KJ, Bly MJ, Grove TB, Ellingrod VL.

Pharmacogenomics J. 2013 Jun;13(3):264-71. doi: 10.1038/tpj.2012.6. Epub 2012 Mar 6.

13.

PON1 hypermethylation and PON3 hypomethylation are associated with risk of cerebral infarction.

Xiao J, Li X, Yuan Q, Zhang S, Qu K, Wu B, Wang Y, Duan S.

Curr Neurovasc Res. 2019 Apr 12. doi: 10.2174/1567202616666190412154407. [Epub ahead of print]

PMID:
30977447
14.

Impact of catechol-O-methyltransferase (COMT) gene polymorphism on promoter methylation status in gastric mucosa.

Tahara T, Shibata T, Arisawa T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Hirata I.

Anticancer Res. 2009 Jul;29(7):2857-61.

15.

Endothelial PAS domain protein 1 gene hypomethylation is associated with colorectal cancer in Han Chinese.

Pan R, Zhou C, Dai J, Ying X, Yu H, Zhong J, Zhang Y, Wu B, Mao Y, Wu D, Ying J, Zhang W, Duan S.

Exp Ther Med. 2018 Dec;16(6):4983-4990. doi: 10.3892/etm.2018.6856. Epub 2018 Oct 12.

16.

Association of COMT genotypes with S-COMT promoter methylation in growth-discordant monozygotic twins and healthy adults.

Schreiner F, El-Maarri O, Gohlke B, Stutte S, Nuesgen N, Mattheisen M, Fimmers R, Bartmann P, Oldenburg J, Woelfle J.

BMC Med Genet. 2011 Sep 1;12:115. doi: 10.1186/1471-2350-12-115.

17.

Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation.

Goodman JE, Jensen LT, He P, Yager JD.

Pharmacogenetics. 2002 Oct;12(7):517-28.

PMID:
12360102
18.
19.

The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.

Suriguga, Li XF, Li Y, Yu CH, Li YR, Yi ZC.

Toxicol Appl Pharmacol. 2013 Dec 15;273(3):635-43. doi: 10.1016/j.taap.2013.10.009. Epub 2013 Oct 18.

PMID:
24141029
20.

MTHFD1 promoter hypermethylation increases the risk of hypertension.

Xu M, Li J, Chen X, Han L, Li L, Liu Y.

Clin Exp Hypertens. 2019;41(5):422-427. doi: 10.1080/10641963.2018.1501057. Epub 2018 Sep 5.

PMID:
30183434

Supplemental Content

Support Center